Bayer back on the uptrend
Geschreven op 27.10.2009Renewed year-on-year growth in underlying EBITDA in the third quarter of 2009:
- HealthCare again strong – weak quarter at CropScience – MaterialScience substantially improved
- Group sales EUR 7,392 million (minus 7.0 percent)
- EBITDA before special items EUR 1,499 million (plus 0.4 percent)
- Net income EUR 249 million (minus 10.1 percent)
- Net cash flow EUR 1,517 million (plus 22.9 percent)
- Full-year Group forecast confirmed
Lees hier het volledige bericht:
http://www.press.bayer.com/baynews/baynews.nsf/ID/2009-0615-e.
« Terug naar overzicht